Inducible chromosomal translocation of AML1 and ETO genes through Cre/loxP-mediated recombination in the mouse

Research output: Contribution to journalResearch articleContributedpeer-review

Contributors

  • Frank Buchholz - , University of California at San Francisco (First author)
  • Yosef Refaeli - , University of California at San Francisco (Author)
  • Andreas Trumpp - , University of California at San Francisco, Swiss Institute for Experimental Cancer Research (ISREC) (Author)
  • J. Michael Bishop - , University of California at San Francisco (Author)

Abstract

Transgenic mice have been used to explore the role of chromosomal translocations in the genesis of tumors. But none of these efforts has actually involved induction of a translocation in vivo. Here we report the use of Cre recombinase to replicate in vivo the t(8;21) translocation found in human acute myeloid leukemia (AML). As in the human tumors, the murine translocation fuses the genes AMU and ETO. We used homologous recombination to place loxP sites at loci that were syntenic with the break points for the human translocation. Cre activity was provided in mice by a transgene under the control of the Nestin promoter, or in cultured B cells by infecting with a retroviral vector encoding Cre. In both instances, Cre activity mediated interchromosomal translocations that fused the AML1 and ETO genes. Thus, reciprocal chromosomal translocations that closely resemble rearrangements found in human cancers can be achieved in mice.

Details

Original languageEnglish
Pages (from-to)133-139
Number of pages7
JournalEMBO reports
Volume1
Issue number2
Publication statusPublished - 2000
Peer-reviewedYes
Externally publishedYes

External IDs

PubMed 11265752

Keywords

Sustainable Development Goals

ASJC Scopus subject areas

Library keywords